Immuno-oncology company Affimed to be delisted from Nasdaq after insolvency filing (AFMD:NASDAQ) – Seeking Alpha

Immuno-oncology company Affimed to be delisted from Nasdaq after insolvency filing (AFMD:NASDAQ)  Seeking Alpha

Read the original article here